1. Home
  2. PLAB vs EVO Comparison

PLAB vs EVO Comparison

Compare PLAB & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAB
  • EVO
  • Stock Information
  • Founded
  • PLAB 1969
  • EVO 1993
  • Country
  • PLAB United States
  • EVO Germany
  • Employees
  • PLAB N/A
  • EVO N/A
  • Industry
  • PLAB Semiconductors
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLAB Technology
  • EVO Health Care
  • Exchange
  • PLAB Nasdaq
  • EVO Nasdaq
  • Market Cap
  • PLAB 1.2B
  • EVO 1.2B
  • IPO Year
  • PLAB 1987
  • EVO 2021
  • Fundamental
  • Price
  • PLAB $22.81
  • EVO $3.50
  • Analyst Decision
  • PLAB Strong Buy
  • EVO Buy
  • Analyst Count
  • PLAB 2
  • EVO 2
  • Target Price
  • PLAB $31.00
  • EVO $5.40
  • AVG Volume (30 Days)
  • PLAB 705.9K
  • EVO 44.3K
  • Earning Date
  • PLAB 08-27-2025
  • EVO 11-05-2025
  • Dividend Yield
  • PLAB N/A
  • EVO N/A
  • EPS Growth
  • PLAB N/A
  • EVO N/A
  • EPS
  • PLAB 1.77
  • EVO N/A
  • Revenue
  • PLAB $856,152,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • PLAB N/A
  • EVO $0.43
  • Revenue Next Year
  • PLAB $5.06
  • EVO $9.72
  • P/E Ratio
  • PLAB $12.85
  • EVO N/A
  • Revenue Growth
  • PLAB N/A
  • EVO N/A
  • 52 Week Low
  • PLAB $16.46
  • EVO $2.84
  • 52 Week High
  • PLAB $31.60
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • PLAB 58.45
  • EVO 43.62
  • Support Level
  • PLAB $21.86
  • EVO $3.43
  • Resistance Level
  • PLAB $22.87
  • EVO $3.55
  • Average True Range (ATR)
  • PLAB 0.77
  • EVO 0.08
  • MACD
  • PLAB -0.05
  • EVO 0.02
  • Stochastic Oscillator
  • PLAB 38.81
  • EVO 63.64

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: